Insights from the 2024 NCPA Digest; the opportunity and risks of AI scribes in pharmacy; and what CMS' $2 drug list means for pharmacies.
Share this post
Pharmacy News Deep Dive: NCPA Digest 2024, AI…
Share this post
Insights from the 2024 NCPA Digest; the opportunity and risks of AI scribes in pharmacy; and what CMS' $2 drug list means for pharmacies.